QC Quality Choice Loratadine Orally Disintegrating Tablets
Superpotent Drug: Out Of Specification (OOS) result for Assay.
142 recalls · Class III, newest first
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Failed Dissolution Specifications
Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.
Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station
Failed Tablet/Capsule Specifications; report of oversized and discolored tablets
Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish
Failed Impurities/Degradation Specifications: out-of-specification results for individual unknown and total impurity at the 12th month room temperature stability test station
Subpotent drug
Failed dissolution specifications
Subpotent Drug: menthol and methyl salicylate below specification
Presence of Foreign Tablets/Capsules: Presence of comingled Sugar Free Honey Lemon cough drops.
Failed Dissolution Specifications
Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable
Defective Container: Lids on unit dose cups are not fully qualified.
Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.
Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.
Failed Content Uniformity Specifications: Failed Uniformity of Dosage Units specifications.
Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for dissolution.
CGMP Deviation: Poor container closure of the bulk storage container